Ob/Gyn Medical News about Pelvic Floor Urinary Incontinence, Urge

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

4. 2008 Exclusive Survey—Earnings: Good news for primary care income

5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Update on Pelvic floor dysfunction
OBG Management, 10/05/09

Judd JP et al. – Combining an anticholinergic and behavioral therapy may treat urge incontinence more effectively than either modality alone in women who are dissatisfied with single therapy. Treatment with 5 mg/day oral extended–release oxybutynin in older patients with some cognitive impairment is well tolerated, the study’s findings suggest, with minimal risk of further cognitive decline or delirium over the short term. The potential that long–term therapy has to harm cognitive function remains, however; data on long–term treatment are needed to illuminate that area. The authors also address the importance of dosing, especially over time, and discuss the lower potential of newer–generation anticholinergics to produce cognitive impairment.

<< Previous
Ureteroscopy during pregnancy

Next >>
The Effect of Water-Based Exercise on Glucose and Insulin...